FRM
Fox Run Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,181
| Closed | -$932K | – | 943 |
|
|
2025
Q1 | $932K | Buy |
+23,181
| New | +$932K | 0.14% | 228 |
|
|
2024
Q4 | – | Sell |
-3,870
| Closed | -$204K | – | 929 |
|
|
2024
Q3 | $204K | Buy |
+3,870
| New | +$204K | 0.05% | 667 |
|
|
2022
Q4 | – | Sell |
-7,665
| Closed | -$371K | – | 677 |
|
|
2022
Q3 | $371K | Buy |
7,665
+1,845
| +32% | +$89.3K | 0.14% | 278 |
|
|
2022
Q2 | $229K | Buy |
+5,820
| New | +$229K | 0.11% | 385 |
|
|
2021
Q3 | – | Sell |
-16,978
| Closed | -$336K | – | 495 |
|
|
2021
Q2 | $336K | Buy |
+16,978
| New | +$336K | 0.31% | 136 |
|
|
2018
Q3 | – | Sell |
-31,627
| Closed | -$263K | – | 623 |
|
|
2018
Q2 | $263K | Buy |
31,627
+20,405
| +182% | +$170K | 0.08% | 485 |
|
|
2018
Q1 | $81K | Sell |
11,222
-10,953
| -49% | -$79.1K | 0.02% | 685 |
|
|
2017
Q4 | $181K | Buy |
+22,175
| New | +$181K | 0.05% | 587 |
|
|
2017
Q3 | – | Sell |
-36,000
| Closed | -$436K | – | 710 |
|
|
2017
Q2 | $436K | Buy |
+36,000
| New | +$436K | 0.15% | 271 |
|
|
2016
Q1 | – | Sell |
-17,200
| Closed | -$180K | – | 443 |
|
|
2015
Q4 | $180K | Buy |
+17,200
| New | +$180K | 0.14% | 319 |
|